Bin Xie
Direktor/Vorstandsmitglied bei Jiangsu Vanguard Pharmaceutical Co., Ltd.
Profil
Bin Xie is currently a Member-Supervisory Board & Sales Director at Jiangsu Vanguard Pharmaceutical Co., Ltd.
He graduated with an undergraduate degree from Nanjing Tech University.
Aktive Positionen von Bin Xie
| Unternehmen | Position | Beginn |
|---|---|---|
Jiangsu Vanguard Pharmaceutical Co., Ltd.
 Jiangsu Vanguard Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Vanguard Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical drugs and proprietary Chinese medicines. Its products include valsartan hydrochlorothiazide tablets, calcium dobesilate capsules, calcium carbonate D3 chewable tablets, irbesartan hydrochlorothiazide tablets, bezafibrate dispersible tablets, aluminum magnesium carbonate chewable tablets, amlodipine maleate dispersible tablets, brucei seed oil soft capsules. The company was founded by Guang Xue He on November 28, 2003 and is headquartered in Nantong, China. | Direktor/Vorstandsmitglied | 01.05.2016 |
Ausbildung von Bin Xie
| Nanjing Tech University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Jiangsu Vanguard Pharmaceutical Co., Ltd.
Jiangsu Vanguard Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Vanguard Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical drugs and proprietary Chinese medicines. Its products include valsartan hydrochlorothiazide tablets, calcium dobesilate capsules, calcium carbonate D3 chewable tablets, irbesartan hydrochlorothiazide tablets, bezafibrate dispersible tablets, aluminum magnesium carbonate chewable tablets, amlodipine maleate dispersible tablets, brucei seed oil soft capsules. The company was founded by Guang Xue He on November 28, 2003 and is headquartered in Nantong, China. | Health Technology |
